Loading insider details...
Beta
Latest Form 4 (Jul 24, 2026): Tax Withholding of 79,391 VYNE shares, $71.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 24, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 79,391 | $71.3K |
| Jul 3, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 12,214 | $7.9K |
| Jun 2, 2026 | VYNE Therapeutics Inc. (VYNE) | Grant/Award | 30,791 | $9.5K |
| Apr 2, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 14,232 | $8.5K |
| Jan 5, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 12,684 | $7.4K |
| Oct 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 12,676 | $4.2K |
| Jul 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 12,676 | $20.9K |
| Jun 3, 2025 | VYNE Therapeutics Inc. (VYNE) | Grant/Award | 8,681 | $7.0K |
| Apr 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 30,498 | $48.2K |
| Jan 23, 2025 | VYNE Therapeutics Inc. (VYNE) | Grant/Award | 730,000 | n/a |